Souvenaid is a Medical food marketed for Alzheimer's disease by Danone (called Dannon in the US), consisting of a cocktail of nutrients including uridine monophosphate, choline, the omega-3 fatty acids EPA and DHA, phospholipids, B vitamins and antioxidants. As of January, 2010, Souvenaid is still being studied in clinical trials, and is not being sold commercially; details can be found at the product website.
The results of its first clinical trial were announced at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in July 2008; the results were later published in the journal Alzheimer's & Dementia.
Concerns have been expressed regarding possible conflicts of interests for this research.
- ICAD Press Release
- Alzheimer Research Forum news report
- http://www.cnn.com/2010/HEALTH/01/08/alzheimer.drink.scan/index.html CNN article on Souvenaid
- http://bmartinmd.com/2010/01/souvenaid-study-problematic.html Souvenaid study problematic